Artra Group
6029
Daiwa Cycle
5888
Asiro
7378
Business Coach
9562
D. Western Therapeutics Institute
4576
JP Stock MarketDetailed Quotes
6961 Enplas
- 5030
- -70-1.37%
20min DelayTrading Dec 17 09:33 JST
48.96BMarket Cap13.13P/E (Static)
5090High5000Low16.50KVolume5060Open5100Pre Close83.11MTurnover1504052wk High0.26%Turnover Ratio9.73MShares492052wk Low415.43EPS TTM31.79BFloat Cap15040Historical High13.13P/E (Static)6.32MShs Float550Historical Low383EPS LYR1.77%Amplitude60.00Dividend TTM0.84P/B100Lot Size1.19%Div YieldTTM
Enplas Key Stats
Quarterly+Annual
YOY
| (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.12%10.6B | -10.50%37.81B | -1.19%9.85B | -21.65%8.75B | -13.63%9.49B | -3.95%9.72B | 28.41%42.24B | 10.52%9.97B | 44.07%11.17B | 39.28%10.98B |
| Cost of revenue | 4.31%5.39B | -4.56%20.8B | 10.08%5.72B | -13.22%4.79B | -9.34%5.11B | -4.80%5.17B | 11.60%21.79B | 1.46%5.2B | 14.87%5.52B | 19.89%5.64B |
| Gross profit | 14.57%5.21B | -16.83%17.01B | -13.47%4.13B | -29.90%3.96B | -18.18%4.37B | -2.95%4.54B | 52.99%20.45B | 22.47%4.77B | 91.62%5.65B | 68.04%5.34B |
| Operating expense | -2.52%3.05B | 6.30%12.36B | 0.70%3.04B | 2.79%3.02B | 7.54%3.17B | 14.98%3.13B | 19.08%11.63B | 19.94%3.02B | 23.37%2.94B | 22.82%2.94B |
| Operating profit | 52.48%2.15B | -47.32%4.65B | -37.83%1.09B | -65.37%938M | -49.75%1.21B | -27.89%1.41B | 144.93%8.82B | 27.08%1.76B | 379.47%2.71B | 206.65%2.4B |
| Net non-operating interest income (expenses) | 13.79%66M | 675.86%225M | 103.03%67M | 600.00%56M | 1,566.67%44M | 744.44%58M | 323.08%29M | 353.85%33M | 300.00%8M | -400.00%-3M |
| Non-operating interest income | 14.67%86M | 216.84%301M | 70.59%87M | 171.43%76M | 425.00%63M | 1,775.00%75M | 111.11%95M | 2,450.00%51M | 180.00%28M | -25.00%12M |
| Non-operating interest expense | 17.65%20M | 15.15%76M | 11.11%20M | 0.00%20M | 26.67%19M | 30.77%17M | 13.79%66M | 20.00%18M | 42.86%20M | 0.00%15M |
| Net investment income | -55.61%87M | 76.34%328M | 567.74%207M | 21.48%-234M | -18.88%159M | -23.74%196M | 39.85%186M | -70.48%31M | -1,093.33%-298M | 345.45%196M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 2M | 94.53%-78M | -86M | 0 | -313.79%-1.43B | 0 | 7M | |||
| Income from associates and other participating interests | 0 | 0 | 0 | 5.46%-346M | 0 | 0 | -148.00%-248M | |||
| Special income (charges) | 32.24%-166M | 84.37%-98M | 145.80%262M | -440.00%-51M | 33.33%-64M | -1,042.31%-245M | -1,550.00%-627M | -186.00%-572M | -92.65%15M | -77.78%-96M |
| Less:Restructuring and mergern&acquisition | 580.00%204M | --106M | --2M | --1M | --73M | --30M | --0 | --0 | --0 | --0 |
| Less:Other special charges | -165.52%-38M | -188.41%-199M | -1,731.25%-293M | 426.67%49M | -8.33%-13M | 323.08%58M | 70.76%-69M | -166.67%-16M | 92.65%-15M | 14.29%-12M |
| Less:Write off | --0 | -72.56%191M | -95.07%29M | --1M | -96.30%4M | --157M | 349.03%696M | 279.35%588M | --0 | --108M |
| Other non-operating income (expenses) | 66.67%-3M | -97.92%1M | 12.50%9M | -80.00%2M | -106.67%-1M | -160.00%-9M | -4.00%48M | 366.67%8M | -28.57%10M | -28.57%15M |
| Income before tax | 51.52%2.14B | -24.85%5.02B | 23.70%1.55B | -71.03%711M | 62.73%1.35B | -34.22%1.41B | 65.73%6.68B | -32.05%1.25B | 238.48%2.45B | 19.28%829M |
| Income tax | -7.00%611M | -18.22%1.5B | 69.81%360M | -55.85%234M | -50.10%253M | 11.36%657M | 30.98%1.84B | -69.84%212M | 197.75%530M | 133.64%507M |
| Net income | 102.38%1.53B | -27.35%3.52B | 14.41%1.19B | -75.25%476M | 240.37%1.1B | -51.48%756M | 84.32%4.84B | -8.76%1.04B | 252.20%1.92B | -32.64%322M |
| Net income continuous operations | 102.38%1.53B | -27.37%3.52B | 14.31%1.19B | -75.21%477M | 240.37%1.1B | -51.48%756M | 84.29%4.85B | -8.76%1.04B | 251.74%1.92B | -32.64%322M |
| Noncontrolling interests | -45.00%11M | -65.92%76M | -41.82%32M | -118.00%-9M | -47.62%33M | -63.64%20M | 125.25%223M | 7.84%55M | 177.78%50M | 215.00%63M |
| Net income attributable to the company | 106.53%1.52B | -25.49%3.44B | 17.55%1.16B | -74.05%486M | 308.85%1.06B | -51.07%735M | 82.79%4.62B | -9.54%986M | 254.73%1.87B | -43.23%260M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 106.53%1.52B | -25.49%3.44B | 17.55%1.16B | -74.05%486M | 308.85%1.06B | -51.07%735M | 82.79%4.62B | -9.54%986M | 254.73%1.87B | -43.23%260M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 106.19%172 | -25.54%390.14 | 17.56%131.36 | -74.11%54.97 | 309.49%120.39 | -51.06%83.42 | 82.49%523.94 | -9.65%111.74 | 254.05%212.36 | -43.41%29.4 |
| Diluted earnings per share | 104.35%169.18 | -26.84%383 | 15.50%128.75 | -74.87%53.36 | 301.70%118.1 | -51.43%82.79 | 82.66%523.49 | -9.78%111.47 | 254.11%212.36 | -43.33%29.4 |
| Dividend per share | 0 | 0.00%60 | 0.00%30 | 0 | 0.00%30 | 0 | 26.32%60 | 20.00%30 | 0 | 33.33%30 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |